Suvik Hitek Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 29-06-2024
- Paid Up Capital ₹ 2.50 Cr
as on 29-06-2024
- Company Age 47 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.64 Cr
as on 29-06-2024
- Revenue 62.44%
(FY 2021)
- Profit 132.08%
(FY 2021)
- Ebitda 323.59%
(FY 2021)
- Net Worth 0.97%
(FY 2021)
- Total Assets 37.73%
(FY 2021)
About Suvik Hitek
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹1.64 Cr.
Balagan Pillai, Anujkumar Shukla, and Anilkumar Parekh serve as directors at the Company.
- CIN/LLPIN
U24231GJ1977PTC003036
- Company No.
003036
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Aug 1977
- Date of AGM
18 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Suvik Hitek?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balagan Pillai  | Director | 30-Mar-2013 | Current |
| Anujkumar Shukla | Director | 29-Jan-2005 | Current |
| Anilkumar Parekh | Director | 23-Mar-2009 | Current |
Financial Performance of Suvik Hitek.
Suvik Hitek Pvt Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 62.44% increase. The company also saw a substantial improvement in profitability, with a 132.08% increase in profit. The company's net worth moved up by a moderate rise of 0.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Suvik Hitek?
In 2022, Suvik Hitek had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Sarabhai Chemicals (India) Private LimitedActive 20 years 11 monthsAnujkumar Shukla and Anilkumar Parekh are mutual person
Frontline Electronics And Machinery Private LimitedActive 32 years 6 monthsAnujkumar Shukla is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 07 Aug 2020 | ₹1.00 M | Open |
Bank Of India Creation Date: 18 May 2016 | ₹9.50 M | Open |
Bank Of India Creation Date: 17 Jul 2007 | ₹3.00 M | Open |
How Many Employees Work at Suvik Hitek?
Unlock and access historical data on people associated with Suvik Hitek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Suvik Hitek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Suvik Hitek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
